Domov › Rak pljuč › Connecticut

Klinične študije za Rak pljuč v Connecticut

30 študij za Rak pljuč išče udeležence na lokacijah v Connecticut.

Mesta v Connecticut

Uradno besedilo študije (angleško)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Greenwich, Greenwich
in še 9

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1/2

Starost 12 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Stamford Hospital/Bennett Cancer Center, Stamford
Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven

Vključevanje udeležencevFaza 3

Starost 70 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
in še 14

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Hartford HealthCare - Avon, Avon
Hartford Hospital, Hartford
Hartford HealthCare - Manchester, Manchester
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Yale University, Smillow Cancer Center, New Haven

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 29. sep. 2026 · NCT06881784

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

Smilow Cancer Hospital - Yale New Haven Health, New Haven
Yale - New Haven Hospital - Yale Cancer Center, New Haven
Smilow Cancer Hospital Phase 1 Unit, New Haven
in še 2

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07519655

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Stamford Hospital ( Site 0083), Stamford

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06312137

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, New Haven

Vključevanje udeležencevFaza 2

Starost 18–95 · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT05061550

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07349537

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Yale University, New Haven
Yale-New Haven Hospital North Haven Medical Center, North Haven
Smilow Cancer Hospital Care Center-Trumbull, Trumbull

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06287775

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Yale University School of Medicine - Yale Cancer Center, New Haven

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT05786924

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Hartford Hospital, Hartford

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Yale University School of Medicine, New Haven

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, New Haven

Vključevanje udeležencevFaza 1/2

Starost 18–75 · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT07038343

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

Yale Cancer Center, New Haven
Norwalk Hospital, Norwalk

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06343402

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT05433142

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Yale University Cancer Center, New Haven

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 15. jul. 2026 · NCT05652686

Integrated Cancer Repository for Cancer Research

Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
in še 11

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Smilow Cancer Hospital (Yale University), New Haven

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT06040541

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
in še 10

Vključevanje udeležencevFaza 2

18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
in še 10

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Yale New Haven Medical Center, New Haven

Vključevanje udeležencevVabljeni zdravi prostovoljci

Starost 18 in več · Vsi spoli · Posodobljeno 5. mar. 2026 · NCT06196008

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Hartford Hospital (site 210), Hartford

Vključevanje udeležencevFaza 1/2

Starost 18–80 · Vsi spoli · Posodobljeno 11. dec. 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Hartford
Massive Bio SYNERGY-AI site, Norwalk

Vključevanje udeležencevOpazovalna študija

Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)

Yale School of Medicine, New Haven

Vključevanje udeležencevOpazovalna študija

Starost 18–99 · Vsi spoli · Posodobljeno 12. avg. 2025 · NCT06412172

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Stamford Hospital, Stamford

Vključevanje udeležencevOpazovalna študija

Starost 50 in več · Vsi spoli · Posodobljeno 5. avg. 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

Trinity Health Of New England, Hartford
The Stamford Health/The Stamford Hospital, Stamford

Vključevanje udeležencevOpazovalna študija

Starost 29–85 · Vsi spoli · Posodobljeno 13. nov. 2024 · NCT06426628

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.